
AVONTEC broadens US patent protection for its lead candidate AVT-01 decoy ODN
AVONTEC GmbH, a privately held biopharmaceutical company dedicated to the development of novel therapies for chronic inf…
AVONTEC GmbH, a privately held biopharmaceutical company dedicated to the development of novel therapies for chronic inf…
AVONTEC GmbH, a privately held bio?pharmaceutical company dedicated to the development of novel therapies for chronic in…
AVONTEC GmbH, a privately held bio-pharmaceutical company dedicated to the development of novel therapies for chronic in…
AVONTEC GmbH, a privately held biopharmaceutical company dedicated to the development of novel therapies for chronic inf…
AVONTEC GmbH, a privately held biopharmaceutical company dedicated to the development of novel therapies for chronic inf…
AVONTEC GmbH, a privately held biopharmaceutical company dedicated to the development of novel therapies for chronic inf…
The biopharmaceutical company AVONTEC GmbH, focused on the development and commercialization of novel therapeutic treatm…
Avontec GmbH, a Martinsried based biopharmaceutical company focused on the development and commercialization of novel th…
Avontec GmbH, a Munich based biopharmaceutical company focused on the development and commercialization of novel therape…